CoChat

Germline BRCA1/2 Mutations and p27Kip1 Protein Levels Independently Predict Outcome After Breast Cancer

Chappuis, Pierre O., Kapusta, Linda, Bégin, Louis R., Wong, Nora, Brunet, Jean-Sébastien, Narod, Steven A., Slingerland, Joyce, Foulkes, William D. · 2000 · Journal of Clinical Oncology
Cited by 119

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

PURPOSE: Decreased levels of the cyclin-dependent kinase inhibitor p27 Kip1 in breast cancer are associated with a poor outcome. The prognostic significance of BRCA1/2 mutations is less clear, and the relationship between BRCA1/2 mutation status, p27 Kip1 protein levels, and outcome has not been studied. PATIENTS AND METHODS: Pathology blocks from 202 consecutive Ashkenazi Jewish women with primary invasive breast cancer were studied. Tumor DNA was tested for the three common BRCA1/2 founder mutations present in Ashkenazi Jews, and p27 Kip1 expression was evaluated by immunohistochemistry. The median follow-up was 6.4 years. RESULTS: Thirty-two tumors (16%) were positive for a BRCA1/2 mutation. Low p27 Kip1 expression was seen in 110 tumors (63%) and was significantly associated with BRCA1/2 mutations (odds ratio, 4.0; 95% confidence interval [CI], 1.4 to 11.1; P = .009). BRCA1/2 mutation carriers had a significantly worse 5-year distant disease-free survival (DDFS) compared with women without BRCA1/2 mutations (58% v 82%; P = .003). Similar results were seen for women whose tumors expressed low levels of p27 Kip1, compared with those with high levels (5-year DDFS, 68% v 93%; P < .0001). In a multivariate analysis, both BRCA1/2 mutation and low p27 Kip1 expression were associated with a shorter DDFS (relative risk [RR], 2.1; 95% CI, 1.0 to 4.3; P = .05; and RR, 3.9; 95% CI, 1.4 to 11.1; P = .01, respectively). CONCLUSION: In this study, we showed that BRCA1/2 mutations were associated with low levels of p27 Kip1 in breast cancer. Both BRCA1/2 and p27 Kip1 status were identified as independent prognostic factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2000.18.24.4045

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 35

  1. 10.1056/NEJM199206253262607 · DOI · Paper page
  2. 10.3322/canjclin.47.1.28 · DOI · Paper page
  3. 10.1093/jnci/90.21.1601 · DOI · Paper page
  4. 10.1146/annurev.med.50.1.401 · DOI · Paper page
  5. 10.1038/18105 · doi:10.1038/18105
  6. 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I · DOI · Paper page
  7. 10.1023/A:1006154900130 · DOI
  8. 10.1038/nm0297-222 · DOI · Paper page
  9. 10.1038/nm0297-227 · DOI · Paper page
  10. 10.1002/(SICI)1096-9098(199904)70:4<230::AID-JSO6>3.0.CO;2-I · doi:10.1002/(sici)1096-9098(199904)70:4<230::aid-jso6>3.0.co;2-i
  11. 10.1038/sj.bjc.6690250 · DOI
  12. 10.1016/S0304-3835(99)00084-1 · doi:10.1016/s0304-3835(99)00084-1
  13. 10.1200/JCO.1998.16.5.1969 · DOI · Paper page
  14. 10.1016/S0140-6736(96)10109-4 · DOI · Paper page
  15. 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W · DOI · Paper page
  16. 10.1093/jnci/90.15.1138 · DOI · Paper page
  17. 10.1038/sj.onc.1202106 · DOI · Paper page
  18. 10.1023/A:1008301314812 · DOI
  19. 10.1200/JCO.1999.17.11.3653 · DOI · Paper page
  20. 10.1093/jnci/91.24.2112 · DOI · Paper page
  21. 10.1007/BF01805951 · doi:10.1007/bf01805951
  22. 10.1200/JCO.1999.17.11.3396 · DOI · Paper page
  23. Tonin P, Weber B, Offit K, et al: Frequency of recurrent and mutations in Ashkenazi Jewish breast cancer families. Nat Med 2: 1183,1996-1196, BRCA1 BRCA2 · DOI · Paper page
  24. 10.1038/ng1096-185 · DOI · Paper page
  25. 10.1093/jnci/91.14.1241 · DOI · Paper page
  26. 10.1002/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y · doi:10.1002/(sici)1097-0142(19970801)80:3<435::aid-cncr11>3.0.co;2-y
  27. 10.1002/(SICI)1096-9896(199901)187:2<200::AID-PATH228>3.0.CO;2-M · DOI
  28. 10.1016/S0140-6736(05)79248-5 · DOI
  29. 10.1200/JCO.2000.18.24.4053 · DOI · Paper page
  30. 10.1038/38291 · DOI · Paper page
  31. Han S, Park K, Kim HY, et al: Reduced expression of p27 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation. Breast Cancer Res Treat 55: 161,1999-167, Kip1 · doi:10.1023/a:1006258222233
  32. 10.1038/8743 · DOI · Paper page
  33. 10.1038/387422a0 · DOI · Paper page
  34. 10.1038/24179 · DOI · Paper page
  35. 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H · DOI · Paper page

Cited by

See all 119

Metadata

Authors
Chappuis, P. O., Kapusta, L., Bégin, L. R., Wong, N., Brunet, J.-S., Narod, S. A., Slingerland, J., & Foulkes, W. D.
Venue
Journal of Clinical Oncology
Published
2000-12-15
Volume
18
Issue
24
Pages
4045-4052
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2258788178
Cited by
119
References
3
FWCI
5.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Germline BRCA1/2 Mutations and p27Kip1 Protein Levels Independently Predict Outcome After Breast Cancer. https://app.cochat.ai/papers/10.1200/jco.2000.18.24.4045
The paper
Chappuis, P. O., Kapusta, L., Bégin, L. R., Wong, N., Brunet, J.-S., Narod, S. A., Slingerland, J., & Foulkes, W. D. (2000). Germline BRCA1/2 Mutations and p27Kip1 Protein Levels Independently Predict Outcome After Breast Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2000.18.24.4045

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.